Showing results (1371-1380 of 5,501) with videos related to
Sort By:
Pageof 551
Inflammatory Bowel Diseases|July 20, 2002
Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activityUrban Sjöqvist, Erik Hertervig, Ake Nilsson, et al.Inflammatory Bowel Diseases|July 20, 2002
Adenocarcinoma of the cecum as the first manifestation of ulcerative colitis complicated by primary sclerosing cholangitis and endomyocardial fibrosisFernando Magro, Manuel Correia, Goreti Moreira, et al.Inflammatory Bowel Diseases|November 27, 2001
Hepatitis B and C virus infection in Crohn's diseaseL Biancone, M Pavia, G Del Vecchio Blanco, et al.Inflammatory Bowel Diseases|November 27, 2001
Clinical outcome of Crohn's disease: analysis according to the vienna classification and clinical activityF T Veloso, J T Ferreira, L Barros, et al.Inflammatory Bowel Diseases|November 27, 2001
Proximal Crohn's disease: review of the clinicopathologic features and therapyR A van Hogezand, A M Witte, R A Veenendaal, et al.Inflammatory Bowel Diseases|March 27, 2003
The effect of 5-aminosalicylic acid-containing drugs on sulfide production by sulfate-reducing and amino acid-fermenting bacteriaLaurie M Edmond, Mark J Hopkins, Elizabeth A Magee, et al.Inflammatory Bowel Diseases|March 27, 2003
Experimental colitis in rats with portal hypertension and liver diseaseZvi Ackerman, Fanny Karmeli, Patrizia Cohen, et al.Inflammatory Bowel Diseases|March 20, 2021
Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical ProgramBruce E Sands, Millie D Long, Walter Reinisch, et al.Inflammatory Bowel Diseases|November 18, 2021
Current Trends in IBD-Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling SystemYunki Y Yau, Valerie C Wasinger, Robert P Hirten, et al.Inflammatory Bowel Diseases|November 18, 2021
Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel DiseasesYi Li, Jianping Chen, Andrew A Bolinger, et al.Pageof 551